Key Takeaways:
5-Year Pilot Program:Â Starting as early as 2026, Medicaid and Medicare may opt to cover GLP-1 weight-loss drugs like Ozempic and Wegovy, expanding access beyond diabetes-related conditions.
Big Costs, Big Market:Â The drugs run up to $7,000 per year, with analysts...
Key Takeaways:
FDA Greenlights Naturals:Â New approvals include gardenia-based blue dye, signaling an industry shift toward transparency and consumer choice.
90% Market Commitment:Â Ice cream makers pledge to remove seven artificial dyes by 2028, opting for natural alternatives like fruit-based colors.
Trump-Era Push:Â Move...
The appointment of Dr. David Weldon by President Donald Trump to lead the Centers for Disease Control and Prevention is a significant victory for those who value medical freedom and social conservatism. This choice has been met with enthusiasm...
Key Takeaways:
Routine Update, Loud Reaction: The Smithsonian removed a temporary Trump impeachment label as part of a larger exhibit update—prompting...
